[English] 日本語

- PDB-9dpe: CryoEM Structure of Human BTN2A1 ectodomain in complex with TCR-b... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 9dpe | ||||||
---|---|---|---|---|---|---|---|
Title | CryoEM Structure of Human BTN2A1 ectodomain in complex with TCR-blocking 2A1.12 Fab | ||||||
![]() |
| ||||||
![]() | IMMUNE SYSTEM / Complex / Antibody / Immune Recognition / SIGNALING PROTEIN | ||||||
Function / homology | ![]() Butyrophilin (BTN) family interactions / regulation of cytokine production / lipid metabolic process / T cell receptor signaling pathway / external side of plasma membrane / signaling receptor binding / plasma membrane Similarity search - Function | ||||||
Biological species | ![]() | ||||||
Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.86 Å | ||||||
![]() | Ramesh, A. / Fuller, J.R. / Roy, S. / Adams, E. | ||||||
Funding support | ![]()
| ||||||
![]() | ![]() Title: Mapping the extracellular molecular architecture of the pAg-signaling complex with α-Butyrophilin antibodies. Authors: Amrita Ramesh / Sobhan Roy / Tomasz Slezak / James Fuller / Hortencia Graves / Murad R Mamedov / Alexander Marson / Anthony A Kossiakoff / Erin J Adams / ![]() Abstract: Target cells trigger Vγ9Vδ2 T cell activation by signaling the intracellular accumulation of phospho-antigen metabolites (pAgs) through Butyrophilin (BTN)-3A1 and BTN2A1 to the Vγ9Vδ2 T cell ...Target cells trigger Vγ9Vδ2 T cell activation by signaling the intracellular accumulation of phospho-antigen metabolites (pAgs) through Butyrophilin (BTN)-3A1 and BTN2A1 to the Vγ9Vδ2 T cell receptor (TCR). An incomplete understanding of the molecular dynamics in this signaling complex hampers Vγ9Vδ2 T cell immunotherapeutic efficacy. A panel of engineered α-BTN3A1 and α-BTN2A1 antibody (mAb) reagents was used to probe the roles of BTN3A1 and BTN2A1 in pAg signaling. Modified α-BTN3A1 mAbs with increased inter-Fab distances establish that tight clustering of BTN3A1 is not necessary to stimulate Vγ9Vδ2 T cell activation, and that antagonism may occur through occlusion of a critical binding interaction between BTN3A1 and a yet unknown co-receptor. Finally, a panel of additional α-BTN2A1 antagonists utilize different biophysical mechanisms to compete with Vγ9Vδ2 TCRs for BTN2A1 binding. The complex structures of BTN2A1 ectodomain and Fabs from three antagonist mAbs provide molecular insights into BTN2A1 epitopes critical for pAg-signaling. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 260.5 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 211 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Arichive directory | ![]() ![]() | HTTPS FTP |
---|
-Related structure data
Related structure data | ![]() 47104MC ![]() 8vc7C C: citing same article ( M: map data used to model this data |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
-
Assembly
Deposited unit | ![]()
|
---|---|
1 |
|
-
Components
#1: Protein | Mass: 25741.371 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: BTN2A1 ectodomain with N- and C-terminal linkers. N-terminal (ADLQ) and C-terminal (VSPCGSGLEVLFQ) residues are disordered and not modeled. 3 glycans are denoted as NAG. Source: (gene. exp.) ![]() ![]() | ||||
---|---|---|---|---|---|
#2: Antibody | Mass: 24775.504 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: Heavy chain of Herceptin Fab scaffold with CDR loops modified through phage-display evolution. (CDR1: FSSSI) (CDR2: SIYSSSGYTY) (CDR3: IEYGRGYWDAF). N-terminal (EIS) is a linker/restriction ...Details: Heavy chain of Herceptin Fab scaffold with CDR loops modified through phage-display evolution. (CDR1: FSSSI) (CDR2: SIYSSSGYTY) (CDR3: IEYGRGYWDAF). N-terminal (EIS) is a linker/restriction enzyme artifact and first residue of Fab, and disordered and not modeled. Source: (gene. exp.) ![]() ![]() ![]() | ||||
#3: Antibody | Mass: 23258.783 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: Light chain of Herceptin Fab scaffold with CDR loops modified through phage-display evolution. (CDR1: VSSAV) (CDR2: IYSASSLY) (CDR3: SSSSLI). N-terminal (S) residue is a linker/restriction enzyme artifact. Source: (gene. exp.) ![]() ![]() ![]() | ||||
#4: Antibody | Mass: 15071.431 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: Human variable heavy-chain domain Nanobody specific for human Fab kappa light chain with a hexahistidine tag and linker (HHHHHHGENLYFQGS). Tag and linker are disordered and not shown. Source: (gene. exp.) ![]() ![]() ![]() | ||||
#5: Sugar | ChemComp-NAG / Has ligand of interest | N | Has protein modification | Y | |
-Experimental details
-Experiment
Experiment | Method: ELECTRON MICROSCOPY |
---|---|
EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
Component |
| ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular weight |
| ||||||||||||||||||||||||||||||||||||||||||
Source (natural) |
| ||||||||||||||||||||||||||||||||||||||||||
Source (recombinant) |
| ||||||||||||||||||||||||||||||||||||||||||
Buffer solution | pH: 7.4 | ||||||||||||||||||||||||||||||||||||||||||
Specimen | Conc.: 0.85 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||||||||||||||||||||||||||||||||
Specimen support | Grid material: GOLD / Grid mesh size: 200 divisions/in. / Grid type: Quantifoil R1.2/1.3 | ||||||||||||||||||||||||||||||||||||||||||
Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 100 % / Chamber temperature: 295 K |
-
Electron microscopy imaging
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
---|---|
Microscopy | Model: TFS KRIOS |
Electron gun | Electron source: ![]() |
Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 2500 nm / Nominal defocus min: 900 nm / Cs: 2.7 mm / C2 aperture diameter: 50 µm |
Specimen holder | Cryogen: NITROGEN / Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
Image recording | Electron dose: 60 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Num. of grids imaged: 1 / Num. of real images: 5438 |
EM imaging optics | Energyfilter name: GIF Bioquantum / Energyfilter slit width: 20 eV |
-
Processing
EM software |
| ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||||||||||||||||||
Particle selection | Num. of particles selected: 898426 | ||||||||||||||||||||||||||||||||||||||||
Symmetry | Point symmetry: C1 (asymmetric) | ||||||||||||||||||||||||||||||||||||||||
3D reconstruction | Resolution: 3.86 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 213773 / Num. of class averages: 1 / Symmetry type: POINT | ||||||||||||||||||||||||||||||||||||||||
Atomic model building | Protocol: FLEXIBLE FIT / Space: REAL / Target criteria: Cross-correlation | ||||||||||||||||||||||||||||||||||||||||
Atomic model building | 3D fitting-ID: 1
|